Amyris Company Profile (NASDAQ:AMRS)

About Amyris

Amyris logoAmyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Specialty Chemicals
  • Sub-Industry: Oil & Gas Refining & Marketing
  • Exchange: NASDAQ
  • Symbol: AMRS
  • CUSIP: 03236M10
Key Metrics:
  • Previous Close: $0.50
  • 50 Day Moving Average: $0.4440
  • 200 Day Moving Average: $0.6376
  • 52-Week Range: $0.31 - $2.57
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.20
  • P/E Growth: -0.0900
  • Market Cap: $136.76M
  • Outstanding Shares: 235,022,000
  • Beta: 0.89
Profitability:
  • Net Margins: -400.17%
  • Return on Assets: -125.36%
Debt:
  • Debt-to-Equity Ratio: -0.66%
  • Current Ratio: 0.17%
  • Quick Ratio: 0.09%
Additional Links:
Companies Related to Amyris:

Analyst Ratings

Consensus Ratings for Amyris (NASDAQ:AMRS) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.20 (534.42% upside)

Analysts' Ratings History for Amyris (NASDAQ:AMRS)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Singular ResearchReiterated RatingBuy$2.80View Rating Details
3/10/2016Cowen and CompanyReiterated RatingMarket Perform$2.50 -> $2.00View Rating Details
11/10/2015Rodman & RenshawInitiated CoverageBuy$4.00View Rating Details
11/10/2015HC WainwrightInitiated CoverageBuy$4.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Amyris (NASDAQ:AMRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q2($0.12)($0.06)$15.23 million$9.60 millionViewN/AView Earnings Details
5/10/2016Q1($0.13)($0.17)$10.39 million$8.80 millionViewListenView Earnings Details
3/9/2016Q4($0.10)($0.16)$32.44 million$9.80 millionViewListenView Earnings Details
11/5/2015Q315($0.14)($0.23)$8.84 million$8.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.31)($0.47)$15.66 million$7.80 millionViewN/AView Earnings Details
5/5/2015Q115($0.20)($0.41)$21.40 million$7.90 millionViewN/AView Earnings Details
2/24/2015Q414($0.27)($0.40)$20.12 million$11.60 millionViewN/AView Earnings Details
11/4/2014Q314($0.24)($0.28)$20.51 million$16.34 millionViewN/AView Earnings Details
8/7/2014Q214($0.30)($0.40)$12.36 million$9.30 millionViewN/AView Earnings Details
5/8/2014Q114($0.28)($0.10)$13.50 million$17.90 millionViewN/AView Earnings Details
2/25/2014Q413($0.24)($0.26)$18.66 millionViewN/AView Earnings Details
10/31/2013Q313($0.30)($0.32)$13.59 million$7.00 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.32)($0.34)$11.47 million$10.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.39)($0.39)$9.80 million$7.87 millionViewN/AView Earnings Details
2/19/2013Q4 2012($0.51)($0.49)$10.68 million$5.90 millionViewN/AView Earnings Details
11/6/2012Q312($0.63)($0.22)$10.49 million$19.10 millionViewN/AView Earnings Details
7/31/2012($0.69)($0.66)ViewN/AView Earnings Details
5/8/2012($0.76)($1.88)ViewN/AView Earnings Details
11/1/2011($0.71)($0.97)ViewN/AView Earnings Details
8/2/2011($0.63)($0.95)ViewN/AView Earnings Details
5/5/2011($0.50)($0.76)ViewN/AView Earnings Details
2/28/2011($0.49)($0.51)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amyris (NASDAQ:AMRS)
Current Year EPS Consensus Estimate: $-0.2 EPS
Next Year EPS Consensus Estimate: $-0.12 EPS

Dividends

Dividend History for Amyris (NASDAQ:AMRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Amyris (NASDAQ:AMRS)
Insider Ownership Percentage: 48.70%
Institutional Ownership Percentage: 35.68%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2016L John DoerrDirectorBuy200,577$1.04$208,600.08View SEC Filing  
10/14/2015Energies Nouvelles Activ TotalDirectorSell80,052$2.36$188,922.72View SEC Filing  
6/5/2015John MeloCEOSell61,276$2.00$122,552.00View SEC Filing  
5/12/2015John MeloCEOSell65,575$2.08$136,396.00View SEC Filing  
5/15/2014L John DoerrDirectorBuy172,186$3.02$520,001.72View SEC Filing  
5/24/2013John MeloCEOSell24,402$2.85$69,545.70View SEC Filing  
3/27/2013Thani Sheikh Abdullah Bin K AlDirectorBuy1,533,742$3.26$4,999,998.92View SEC Filing  
12/24/2012Thani Sheikh Abdullah Bin K AlDirectorBuy3,355,704$2.98$9,999,997.92View SEC Filing  
8/31/2012John MeloCEOSell668,730$3.70$2,474,301.00View SEC Filing  
8/31/2012L John DoerrDirectorBuy270,270$3.70$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Amyris (NASDAQ:AMRS)
DateHeadline
prnewswire.com logoGinkgo Bioworks Unveils Next Generation Organism Foundry to Bring Biotech into New Markets (NASDAQ:AMRS)
www.prnewswire.com - September 30 at 3:55 PM
streetinsider.com logoAmyris (AMRS) Enters New Funding Arrangement, Expanded Nutraceutical Collaboration (NASDAQ:AMRS)
www.streetinsider.com - September 30 at 3:55 PM
finance.yahoo.com logoCan The Uptrend Continue for Amyris (AMRS)? (NASDAQ:AMRS)
finance.yahoo.com - September 30 at 3:55 PM
News IconAmyris Inc (AMRS) Stock Gaining Big On Funding And Collaboration News (NASDAQ:AMRS)
feedproxy.google.com - September 30 at 3:46 PM
finance.yahoo.com logoAmyris Expands in Global Nutraceuticals Market with New Collaboration and Partner Funding of $30 Million (NASDAQ:AMRS)
finance.yahoo.com - September 30 at 8:38 AM
News IconInsider Trading and Upgrades/Downgrades for Amyris, Inc. (NASDAQ:AMRS) - Newburgh Press (NASDAQ:AMRS)
newburghpress.com - September 29 at 3:42 PM
News Icon2 Stocks Analyst-Opinion Need Close Attention Cobalt International ... - The Voice Registrar (NASDAQ:AMRS)
voiceregistrar.com - September 28 at 8:17 AM
News IconUnder the Microscope: Zeroing in on Shares of Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 26 at 8:28 PM
capitalcube.com logoETF’s with exposure to Amyris, Inc. : September 26, 2016 (NASDAQ:AMRS)
www.capitalcube.com - September 26 at 3:27 PM
News IconUnder the Microscope, Zeroing in at Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 23 at 3:54 PM
News IconKeen Investors Find News on Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 23 at 3:54 PM
News IconPenny Stock Investors Keen on Shares of Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 21 at 4:23 PM
News IconTrending Stocks: EnteroMedics Inc (NASDAQ:ETRM), Amyris Inc (NASDAQ:AMRS) - NYSE Journal (press release) (NASDAQ:AMRS)
stockznews.com - September 21 at 4:23 PM
News IconPenny Stock Investors Take an Interest in Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 20 at 3:29 PM
News IconAmyris Inc (NASDAQ:AMRS) & Baxter International Inc (NYSE:BAX ... - Money News (NASDAQ:AMRS)
www.newsismoney.com - September 19 at 4:25 PM
News IconBasic materials stocks for your portfolio: QEP Resources, Inc. (QEP), Amyris, Inc. (AMRS) - The Independent Republic (NASDAQ:AMRS)
theindependentrepublic.com - September 19 at 8:14 AM
News IconAmyris, Inc.'s (AMRS): Stock to Watch - Hot Stocks Point (NASDAQ:AMRS)
www.hotstockspoint.com - September 19 at 8:14 AM
4-traders.com logoAmyris : & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products (NASDAQ:AMRS)
www.4-traders.com - September 18 at 8:16 AM
News IconAMRS Amyris, Inc. $AMRS Company (NASDAQ:AMRS)
investorshangout.com - September 18 at 8:16 AM
News IconBasic materials stocks for your portfolio: Commercial Metals Company (CMC), Amyris, Inc. (AMRS) - The Independent Republic (NASDAQ:AMRS)
theindependentrepublic.com - September 16 at 3:29 PM
News IconStocks Faring Away From Broker's Choice: AcelRx Pharmaceuticals (NASDAQ:ACRX), Amyris (AMRS), CME Group ... - Street Wise Report (press release) (blog) (NASDAQ:AMRS)
streetwisereport.com - September 16 at 3:29 PM
News IconAmyris, Inc. (NASDAQ:AMRS) Sale Analysis - Newburg Press (NASDAQ:AMRS)
newburghpress.com - September 16 at 3:29 PM
nasdaq.com logoAmyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22 (NASDAQ:AMRS)
www.nasdaq.com - September 16 at 12:10 PM
finance.yahoo.com logoAmyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22, 2016 (NASDAQ:AMRS)
finance.yahoo.com - September 16 at 12:10 PM
News IconKeen Investors Narrowing Their Focus on Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 15 at 12:23 PM
publicnow.com logoAmyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products (NASDAQ:AMRS)
www.publicnow.com - September 15 at 12:23 PM
News IconKeen Investors Narrowing Their Focus on Amyris, Inc. (NASDAQ ... - Duncan Research (NASDAQ:AMRS)
www.duncanindependent.com - September 14 at 8:45 PM
News IconBasic materials stocks for your portfolio: Amyris, Inc. (AMRS), Jones Energy, Inc. (JONE) - The Independent Republic (NASDAQ:AMRS)
theindependentrepublic.com - September 12 at 3:29 PM
News IconAmyris, Inc. (NASDAQ:AMRS) Quarterly Analysis - Newburg Press (NASDAQ:AMRS)
newburghpress.com - September 12 at 3:29 PM
zacks.com logoIs Amyris (AMRS) Stock a Solid Choice Right Now? (NASDAQ:AMRS)
www.zacks.com - September 12 at 8:17 AM
biz.yahoo.com logoAMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (NASDAQ:AMRS)
biz.yahoo.com - September 10 at 8:14 AM
finance.yahoo.com logoAmyris in Partnership with Boticário Group Named Gold Winner by Cosmetics Design for Breakthrough Ingredient ─ Neossance® Hemisqualane (NASDAQ:AMRS)
finance.yahoo.com - September 9 at 3:27 PM
capitalcube.com logoETF’s with exposure to Amyris, Inc. : September 9, 2016 (NASDAQ:AMRS)
www.capitalcube.com - September 9 at 3:27 PM
istreetwire.com logoStocks in Focus: Amyris, Inc. (AMRS), U.S. Silica Holdings, Inc. (SLCA), Progenics Pharmaceuticals, Inc. (PGNX) - iStreetWire (NASDAQ:AMRS)
istreetwire.com - September 8 at 3:27 PM
News IconBasic Materials Stocks To Look Out For: Amyris, Inc. (AMRS), Alon USA Energy, Inc. (ALJ) - The Independent Republic (NASDAQ:AMRS)
theindependentrepublic.com - September 8 at 3:27 PM
finance.yahoo.com logoAmyris to Present at Rodman & Renshaw 18th Annual Global Investment Conference on September 12, 2016 (NASDAQ:AMRS)
finance.yahoo.com - September 7 at 12:26 PM
investopedia.com logoWho Is Driving Apple's Management Team? (APPL) (NASDAQ:AMRS)
www.investopedia.com - September 2 at 3:30 PM
News IconAmyris, Inc.'s (AMRS): Traders Alert - Hot Stocks Point (NASDAQ:AMRS)
www.hotstockspoint.com - August 25 at 8:18 AM
nasdaq.com logoBiossance™ Launches The Detoxifier - A Breakthrough, Innovative Modeling Mask (NASDAQ:AMRS)
www.nasdaq.com - August 24 at 11:45 AM
publicnow.com logoBiossance™ Launches The Detoxifier ─ A Breakthrough, Innovative Modeling Mask (NASDAQ:AMRS)
www.publicnow.com - August 24 at 11:45 AM
capitalcube.com logoETF’s with exposure to Amyris, Inc. : August 23, 2016 (NASDAQ:AMRS)
www.capitalcube.com - August 23 at 3:29 PM
capitalcube.com logoETF’s with exposure to Amyris, Inc. : August 23, 2016 (NASDAQ:AMRS)
www.capitalcube.com - August 23 at 3:29 PM
News IconAmyris, Inc. (NASDAQ:AMRS), Biossance Introduces The Illuminator - Journal Transcript (NASDAQ:AMRS)
www.journaltranscript.com - August 19 at 4:06 PM
finance.yahoo.com logoAMYRIS, INC. Financials (NASDAQ:AMRS)
finance.yahoo.com - August 19 at 4:06 PM
News IconAmyris, Inc.'s (AMRS): Stocks on Trader's Radar - Hot Stocks Point (NASDAQ:AMRS)
www.hotstockspoint.com - August 18 at 3:36 PM
News IconAmyris Inc (NASDAQ:AMRS) & Wynn Resorts, (NASDAQ:WYNN) Notable Runners - Money News (press release) (NASDAQ:AMRS)
www.newsismoney.com - August 18 at 3:36 PM
4-traders.com logoAmyris : Biossance™ Launches The Illuminator ─ A Clinically Proven, Weightless Eye Gel (NASDAQ:AMRS)
www.4-traders.com - August 18 at 11:53 AM
News IconAmyris: The New Colossus Aims To Unlock Its Golden Door (NASDAQ:AMRS)
www.altenergystocks.com - August 17 at 8:58 PM
seekingalpha.com logoAmyris - A Juggernaut In The Making (NASDAQ:AMRS)
seekingalpha.com - August 17 at 8:58 PM
streetinsider.com logoAmyris (AMRS) Announces Biossance Launches The Illuminator (NASDAQ:AMRS)
www.streetinsider.com - August 17 at 8:58 PM

Social

Amyris (NASDAQ:AMRS) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff